Your browser doesn't support javascript.
loading
Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies.
Bonsignori, Mattia; Kreider, Edward F; Fera, Daniela; Meyerhoff, R Ryan; Bradley, Todd; Wiehe, Kevin; Alam, S Munir; Aussedat, Baptiste; Walkowicz, William E; Hwang, Kwan-Ki; Saunders, Kevin O; Zhang, Ruijun; Gladden, Morgan A; Monroe, Anthony; Kumar, Amit; Xia, Shi-Mao; Cooper, Melissa; Louder, Mark K; McKee, Krisha; Bailer, Robert T; Pier, Brendan W; Jette, Claudia A; Kelsoe, Garnett; Williams, Wilton B; Morris, Lynn; Kappes, John; Wagh, Kshitij; Kamanga, Gift; Cohen, Myron S; Hraber, Peter T; Montefiori, David C; Trama, Ashley; Liao, Hua-Xin; Kepler, Thomas B; Moody, M Anthony; Gao, Feng; Danishefsky, Samuel J; Mascola, John R; Shaw, George M; Hahn, Beatrice H; Harrison, Stephen C; Korber, Bette T; Haynes, Barton F.
Afiliación
  • Bonsignori M; Department of Medicine, Duke University School of Medicine, Duke University Medical Center, Durham, NC 27710, USA. mattia.bonsignori@dm.duke.edu btk@lanl.gov barton.haynes@dm.duke.edu.
  • Kreider EF; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Fera D; Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Meyerhoff RR; Laboratory of Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Bradley T; Department of Medicine, Duke University School of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
  • Wiehe K; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Alam SM; Department of Medicine, Duke University School of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
  • Aussedat B; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Walkowicz WE; Department of Medicine, Duke University School of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
  • Hwang KK; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Saunders KO; Department of Medicine, Duke University School of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
  • Zhang R; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Gladden MA; Department of Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Monroe A; Department of Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Kumar A; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Xia SM; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Cooper M; Department of Surgery, Duke University School of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
  • Louder MK; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • McKee K; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Bailer RT; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Pier BW; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Jette CA; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Kelsoe G; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Williams WB; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Morris L; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Kappes J; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Wagh K; Laboratory of Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Kamanga G; Laboratory of Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Cohen MS; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Hraber PT; Department of Immunology, Duke University School of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
  • Montefiori DC; Department of Medicine, Duke University School of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
  • Trama A; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Liao HX; National Institute for Communicable Diseases, Johannesburg 2131, South Africa.
  • Kepler TB; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Moody MA; Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
  • Gao F; University of North Carolina Project, Kamuzu Central Hospital, Lilongwe, Malawi.
  • Danishefsky SJ; Departments of Medicine, Epidemiology, and Microbiology and Immunology, University of North Carolina, Chapel Hill, NC 27599, USA.
  • Mascola JR; Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
  • Shaw GM; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Hahn BH; Department of Surgery, Duke University School of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
  • Harrison SC; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Korber BT; Department of Medicine, Duke University School of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
  • Haynes BF; Duke Human Vaccine Institute, Durham, NC 27710, USA.
Sci Transl Med ; 9(381)2017 03 15.
Article en En | MEDLINE | ID: mdl-28298420
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Polisacáridos / VIH-1 / Anticuerpos Neutralizantes Tipo de estudio: Prognostic_studies Límite: Humans / Male Idioma: En Revista: Sci Transl Med Asunto de la revista: CIENCIA / MEDICINA Año: 2017 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Polisacáridos / VIH-1 / Anticuerpos Neutralizantes Tipo de estudio: Prognostic_studies Límite: Humans / Male Idioma: En Revista: Sci Transl Med Asunto de la revista: CIENCIA / MEDICINA Año: 2017 Tipo del documento: Article